China vs Sur: New or unknown treatment history cases: Pulmonary, bacteriologically
China
326,625
in 2023
Sur
85
in 2023
China rank
3rd
Sur rank
1st
New or unknown treatment history cases: Pulmonary, bacteriologically over time
- China
- Sur
How they compare
China currently reports 326,625 against 85 in Sur, a difference of 326,540.
That makes China's figure about 3,842.6 times Sur's.
Across all 11 years both countries report, China has been ahead every year.
China ranks 3rd and Sur ranks 1st of 197 countries.
China has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | China | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 241,700 | 93 | 241,607 | China |
| 2020s | 297,397 | 79.75 | 297,317 | China |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new or unknown treatment history cases: pulmonary, bacteriologically, China or Sur?
- China, at 326,625 against 85 in Sur as of 2023.
- What is the difference in new or unknown treatment history cases: pulmonary, bacteriologically between China and Sur?
- 326,540, with China ahead.
- How many years of comparable data are there for China and Sur?
- 11 years are reported by both, from 2013 to 2023.
- How do China and Sur rank globally for new or unknown treatment history cases: pulmonary, bacteriologically?
- China ranks 3rd and Sur ranks 1st of 197 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New or unknown treatment history cases: Pulmonary, bacteriologically confirmed. Statizoid refreshes it automatically from the source and publishes the full history for both places.